Neuroprotective effects of testosterone treatment in men with multiple sclerosis. - Wikidata - awgldk - TriplyDB

Neuroprotective effects of testosterone treatment in men with multiple sclerosis.

Neuroprotective effects of testosterone treatment in men with multiple sclerosis.

http://www.wikidata.org/entity/Q37634705

about

Androgen Modulation of Hippocampal Structure and Function Brain Gray Matter Changes Associated with Mindfulness Meditation in Older Adults: An Exploratory Pilot Study using Voxel-based Morphometry The role of hormones on Toxoplasma gondii infection: a systematic review.Emerging Approaches for Validating and Managing Multiple Sclerosis Relapse.Hormonal and gender-related immune changes in multiple sclerosis.The Level of Testosterone, Vitamin D, and Irregular Menstruation More Important than Omega-3 in Non-Symptomatic Women Will Define the Fate of Multiple Scleroses in Future.The importance of studying sex differences in disease: The example of multiple sclerosis.Testicular hypofunction and multiple sclerosis risk: a record-linkage study.Single-nucleotide polymorphism rs948854 in human galanin gene and multiple sclerosis: a gender-specific risk factor.Exploring the potential of natural and synthetic neuroprotective steroids against neurodegenerative disorders: A literature review.Testosterone depletion increases the susceptibility of brain tissue to oxidative damage in a restraint stress mouse model.Neurotrophic and Neuroregenerative Effects of GH/IGF1.A Systems Medicine Approach Reveals Disordered Immune System and Lipid Metabolism in Multiple Sclerosis Patients.Male factor infertility and risk of multiple sclerosis: A register-based cohort study.Kallmann syndrome patient with gender dysphoria, multiple sclerosis, and thrombophilia.Cell-specific and region-specific transcriptomics in the multiple sclerosis model: Focus on astrocytes.Male-specific IL-33 expression regulates sex-dimorphic EAE susceptibility.Sex chromosome contributions to sex differences in multiple sclerosis susceptibility and progression.Association of sex hormones and glucose metabolism with the severity of multiple sclerosis.Studies of Mast Cells: Adventures in Serendipity.Mast Cells and Innate Lymphoid Cells: Underappreciated Players in CNS Autoimmune Demyelinating Disease.Androgen-Induced Immunosuppression.Estriol-mediated neuroprotection in multiple sclerosis localized by voxel-based morphometry Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches

P2860

Q26824746-3F59C216-A9EB-414D-88FA-CA9681647500 Q28256133-403DB31F-692E-4567-84B0-B32BF732A855 Q34312110-FF4D453D-DE5F-4582-99CB-6F918DDE631F Q37729523-1124692F-AB4D-4449-8D4F-BFA3653B6FC4 Q38517191-6EE60D38-294F-415A-B601-A5725FC05AFF Q38783057-06C76E7C-59B2-42D2-AF9D-C2922FDEFEE8 Q39015338-ECEBCF2C-4911-4337-BA70-FE2949E9B356 Q39143893-A4365DF1-7EAD-47C8-B724-F1C0A780B935 Q39168246-E46251AF-2ABF-419D-91BE-C429AB710384 Q39428788-FE082C23-2D0F-45C1-8ABF-59131E07740F Q46667234-7C902841-2404-4625-BE4F-3BBF541056B1 Q47152037-436FBE5D-AA25-4F7E-B37E-1DA4568DB44C Q47342256-AD99F508-41E8-4A23-B861-55E5EB88CEE7 Q47598299-B58F5224-5A56-4CF0-B017-A746E883048A Q48297715-86BF7065-EB93-47C7-8DE1-596FB01DF85E Q49568258-D73C1506-0DCD-49A5-969A-3ED4C87255DE Q49596719-C0785122-EBC5-4DFB-AC9E-BFA4EDB3868E Q50146321-651ADB4B-A26F-4730-9637-93E4B3E261DE Q51296580-68358E3E-86B5-468C-AEAA-51048427A7C1 Q52624469-B7171C86-61AE-4A17-9BD9-301E51FB28B4 Q55027295-35D1E8ED-8A4A-4D24-B7E9-14B305FC08BA Q55357541-9EBF9DFF-6901-44EC-8144-63B621503A31 Q58704396-9C75C024-0D99-4A80-9941-12AB540B89ED Q58737028-554212A2-CAD7-4CFB-9DFC-3D4CB4FDFD30

P2860

Neuroprotective effects of testosterone treatment in men with multiple sclerosis.

http://www.wikidata.org/entity/Q37634705

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Neuroprotective effects of testosterone treatment in men with multiple sclerosis.

@en

Neuroprotective effects of testosterone treatment in men with multiple sclerosis.

@nl

type

label

Neuroprotective effects of testosterone treatment in men with multiple sclerosis.

@en

Neuroprotective effects of testosterone treatment in men with multiple sclerosis.

@nl

prefLabel

Neuroprotective effects of testosterone treatment in men with multiple sclerosis.

@en

Neuroprotective effects of testosterone treatment in men with multiple sclerosis.

@nl

P1433

Q37634705-471D081C-C6AB-409F-803E-B54F97E3E161

P1476

Q37634705-1E202EDB-64D1-4045-B13F-A623AA706460

P2093

Q37634705-02F28CA6-A0E6-48D2-B6D8-595CC31DE1A0

Q37634705-2DFE1D9E-B3DF-4942-BCEE-E5073FE1F09A

Q37634705-62A4A98A-9B01-4992-88DA-ABD50039CBFA

Q37634705-BFD82630-59B8-471D-A59A-63D44381FF2A

Q37634705-DE739CF2-733D-4BE2-9192-C30E9722DBA5

Q37634705-F1A66CBC-BDB9-4BD8-8C5A-9FB3DA31ADE6

Q37634705-F845EDD3-8660-42A8-B6ED-1C266A71B12C

P2860

Q37634705-0BEF6EF6-CE59-438E-BC35-0995138F187A

Q37634705-10CCB0F8-B796-4F5D-90EE-F4D1E22B2829

Q37634705-12A932F5-68EC-47AB-946C-4D760CC763B0

Q37634705-13E97617-F14A-49B7-AE80-B618C6F77ADB

Q37634705-1FB30EE0-77CA-4F26-BD40-B00EFA4704D4

Q37634705-2178F3E3-61FD-4BF0-AE96-03C3880B31F5

Q37634705-231DD8CC-30BB-4FE8-8FFC-BB63D849C4C5

Q37634705-23E797F3-ED28-4F7D-BD85-D88184834162

Q37634705-2C7257A0-E2C5-4BA6-9E9D-1AA0F9EAEC1B

Q37634705-31D3E147-1601-43E2-AA18-F2090AC47DE1

P304

Q37634705-C41BB690-AC38-4D14-975A-804C8B6942FE

P31

Q37634705-EC09C1D5-B391-4F6C-B075-50138E2FF953

P356

Q37634705-A56ACCA3-1473-4A9B-A533-602D4D9BA6E9

P478

Q37634705-A851E1A3-F0C7-4594-8CC0-64981B574554

P50

Q37634705-958F0BDE-D6CA-47F9-951D-F8C47B21E354

Q37634705-98C6B5E0-DCD4-4E13-8B73-3DC6736240FC

P577

Q37634705-7C4CC4E9-D6BC-499E-8544-6A3CDC702197

P5875

Q37634705-D71620FE-4505-4FF7-BA6B-5C7EC8CFD95A

P698

Q37634705-511CC22E-F52E-4A61-A645-EE068C3FB007

P921

Q37634705-32E7905E-9B2E-47BD-B180-9B5771825600

P932

Q37634705-2CD94AA3-C311-40A1-93FB-D905F759228D

P356

J.NICL.2014.03.001

P1433

NeuroImage: Clinical

P1476

Neuroprotective effects of testosterone treatment in men with multiple sclerosis.

@en

P2093

Allan Mackenzie-Graham

http://www.w3.org/2001/XMLSchema#string

Barbara S Giesser

http://www.w3.org/2001/XMLSchema#string

Florian Kurth

http://www.w3.org/2001/XMLSchema#string

Michael J Montag

http://www.w3.org/2001/XMLSchema#string

Nancy L Sicotte

http://www.w3.org/2001/XMLSchema#string

Rhonda R Voskuhl

http://www.w3.org/2001/XMLSchema#string

Ronald S Swerdloff

http://www.w3.org/2001/XMLSchema#string

P2860

Why sex matters: brain size independent differences in gray matter distributions between men and women

A fast diffeomorphic image registration algorithm

BrainSuite: An automated cortical surface identification tool

Advances in functional and structural MR image analysis and implementation as FSL

Neuroplasticity: changes in grey matter induced by training

Accurate, robust, and automated longitudinal and cross-sectional brain change analysis.

Imaging cognition II: An empirical review of 275 PET and fMRI studies.

Quantification and clinical relevance of brain atrophy in multiple sclerosis: a review.

The histopathology of grey matter demyelination in multiple sclerosis.

Sample size requirements for treatment effects using gray matter, white matter and whole brain volume in relapsing-remitting multiple sclerosis

P304

454-460

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NICL.2014.03.001

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Christian Gaser

P577

2014-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260843028

http://www.w3.org/2001/XMLSchema#string

P698

24634831

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

3952353

http://www.w3.org/2001/XMLSchema#string